| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $34.33M | - | |
| CEO | 411.2K | $32.69M | - | |
| CFO | 230.9K | $18.35M | - | |
| VP | 158.5K | $12.60M | - | |
| Other | 91.3K | $7.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 40,000 | $65.77 | $2,630,863.64 | -1.5% | +0.4% | -9.1% | |
| Mar 5, 2024 | Mutz Christopher | Head Of Rare Disease | Sell | 5,000 | $66.00 | $330,000.00 | -5.4% | -2.9% | -8.7% | |
| Mar 4, 2024 | Pera Antonio R58 | Director | Sell | 7,000 | $65.20 | $456,400.00 | -20.8% | -4.5% | -11.0% | |
| Feb 13, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $56.04 | $14,010.00 | -0.7% | +22.4% | +8.5% | |
| Jan 23, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 25,216 | $56.17 | $1,416,466.08 | -0.9% | +15.9% | +2.7% | |
| Jan 18, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 24,784 | $55.29 | $1,370,305.20 | -0.9% | +17.8% | +5.2% | |
| Jan 12, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $56.43 | $14,107.50 | -0.7% | +20.0% | -3.0% | |
| Dec 19, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $52.55 | $2,627,250.00 | -1.7% | +28.2% | +2.2% | |
| Dec 11, 2023 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $49.21 | $12,302.50 | -0.7% | +31.5% | +17.6% | |
| Nov 17, 2023 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 13,000 | $51.00 | $663,000.00 | -1.3% | +12.0% | +10.1% |